The Prokaryotic Expression of Cyclin-Dependent Kinase 2, and the Establish of Its Inhibitor Screening System

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  2016-11-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-981-10-4801-2_13
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting CDK4 and CDK6: From Discovery to Therapy.

  2016cited by this paper
• Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.

  2016cited by this paper
• Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors

  2015cited by this paper
• CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.

  2014cited by this paper
• The SH2 Domain Regulates c-Abl Kinase Activation by a Cyclin-Like Mechanism and Remodulation of the Hinge Motion

  2014cited by this paper
• An integrated understanding of the physiological response to elevated extracellular phosphate

  2013cited by this paper
• Molecular Basis for Viral Selective Replication in Cancer Cells: Activation of CDK2 by Adenovirus-Induced Cyclin E

  2013cited by this paper
• Cdks, cyclins and CKIs: roles beyond cell cycle regulation

  2013cited by this paper
• Physiological relevance of cell cycle kinases.

  2011cited by this paper
• The CDK inhibitors in cancer research and therapy

  2011cited by this paper
• Cell cycle, CDKs and cancer: a changing paradigm

  2009cited by this paper
• Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors.

  2009cited by this paper
• An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA.

  2008cited by this paper
• Mammalian cyclin-dependent kinases.

  2005cited by this paper
• High-Throughput Screening with Quantitation of ATP Consumption: A Universal Non-Radioisotope, Homogeneous Assay for Protein Kinase

  2004cited by this paper
• Cyclin-dependent kinases.

  2001cited by this paper
• Regulation of cell cycle molecules by the Ras effector system.

  2001cited by this paper
• Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

  1998cited by this paper
• Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.

  1997cited by this paper

• No citing papers are available for this paper.